Advertisement

CDC Panel Recommends Nasal Flu Vaccine Over Shot for Kids — Physician’s First Watch

Medical News |
June 27, 2014

CDC Panel Recommends Nasal Flu Vaccine Over Shot for Kids

By Kristin J. Kelley

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The live attenuated influenza vaccine nasal spray (FluMist) should be the first choice against influenza for healthy children aged 2 to 8 years, according to a vote on Wednesday by the CDC's Advisory Committee on Immunization Practices.

The vote was based on studies indicating that the spray vaccine is more effective than the shot at preventing flu in children, the Associated Press reports. In some studies, children who received the vaccine intranasally were about half as likely to get influenza as those who received a flu shot.

The American Academy of Pediatrics objects to the panel's preference, however, noting that FluMist costs more than the shot and can't be used by everyone.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement